Trinity Biotech (TRIB) EBIT Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) EBIT Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -58.40% |
| Sep 30, 2024 | -31.41% |
| Jun 30, 2024 | -39.92% |
| Mar 31, 2024 | -33.90% |
| Dec 31, 2023 | -31.76% |
| Sep 30, 2023 | -41.34% |
| Jun 30, 2023 | -60.36% |
| Mar 31, 2023 | -33.05% |
| Dec 31, 2022 | -64.57% |
| Sep 30, 2022 | -48.91% |
| Jun 30, 2022 | -24.65% |
| Mar 31, 2022 | -23.98% |
| Dec 31, 2021 | -1.03% |
| Sep 30, 2021 | 0.37% |
| Jun 30, 2021 | -37.88% |
| Mar 31, 2021 | 11.02% |
| Dec 31, 2020 | 23.69% |
| Sep 30, 2020 | 25.05% |
| Jun 30, 2020 | -30.14% |
| Mar 31, 2020 | -17.14% |